Mitsubishi Tanabe Pharma Corporation reported consolidated earnings results for the six months ended September 30, 2019. For the period, the company reported net sales of JPY 188,109 million against JPY 209,710 million a year ago. Operating profit was JPY 12,561 million against JPY 34,503 million a year ago. Profit for the period was JPY 6,188 million against JPY 23,171 million a year ago. Basic earnings per share were JPY 14.83 against JPY 44.57 a year ago.

For the full year ending March 31, 2020, the company now expects revenue of JPY 376,000 million, operating profit of JPY 10,000 million and profit for the period of JPY 4,000 million.